8/24 with PR (4 confirmed in urothelial, head&neck, melanoma, and anal cancer). 1 pt w/ FGFR3-TACC3 in urothelial cancer had complete shrinkage for 4M. This evidence concerns the gene FGFR3 and anal carcinoma.